文献速递妇科

妇科癌症患者经济毒性的危险因素

Risk factors for financial toxicity in patients with gynecologic cancer.
PubMed 文献 · Am J Obstet Gynecol · 2021-12-11

本研究利用机构数据库识别2016年1月至2018年12月治疗的妇科癌症患者,排除浸润前病变,以客观指标定义经济毒性。4655例中1155例(25%)发生经济毒性,多因素分析显示年轻、无伴侣、黑人和西班牙裔、商业保险、更多影像学检查及更多门诊医生访视与经济毒性显著相关。

要点

  • 经济毒性定义为出现以下至少1项:≥2次账单被催收、申请或获批支付计划、和解、破产、财务援助项目入组或财务相关社工访视。
  • 4655例妇科癌症患者中1155例(25%)发生经济毒性。
  • 多因素分析中年轻、无伴侣、黑人和西班牙裔、商业保险、更多影像学检查及更多门诊医生访视与经济毒性显著相关。

核心结论

  • 经济毒性是妇科癌症患者日益增多的问题。
  • 利用客观经济毒性指标的分析提示,人口学因素和医疗利用指标可用于主动识别经济毒性高危患者。

研究设计与样本

  • 利用机构数据库识别2016年1月至2018年12月治疗的妇科癌症患者,排除浸润前病变。
  • 经济毒性按机构衍生指标定义为出现以下至少1项:≥2次账单被催收、申请或获批支付计划、和解、破产、财务援助项目入组或财务相关社工访视。
  • 临床特征从首次经济毒性事件发生时或未发生毒性者随机选择的治疗日期起回顾2年收集。
  • 采用卡方检验评估危险因素,单因素分析中所有显著变量纳入逻辑回归模型。
  • 共纳入4655例患者进行分析。

主要发现

  • 4655例中1155例(25%)发生经济毒性。
  • 单因素分析中,宫颈癌(35%)、3期或4期疾病(分别为24%和30%)、年轻年龄(<30岁为35%)、无伴侣婚姻状态(31%)、黑人或西班牙裔种族和族裔(分别为45%和37%)、自费(48%)或商业保险(30%)、临床试验参与(31%)、更多影像学检查(≥9次为39%)、≥1次急诊就诊(36%)、更长住院时间(≥20天为36%)及更多门诊医生访视(≥20次为41%)与经济毒性显著相关(P<.01)。
  • 多因素分析中,年轻年龄、无伴侣婚姻状态、黑人和西班牙裔种族和族裔、商业保险、更多影像学检查及更多门诊医生访视与经济毒性显著相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The cost of cancer care is high and rising. Evidence of increased patient cost burden is prevalent in the medical literature and has been defined as "financial toxicity," the financial hardship and financial concerns experienced by patients because of a disease and its related treatments. With targeted therapies and growing out-of-pocket costs, patient financial toxicity is a growing concern among patients with gynecologic cancer. OBJECTIVE: This study aimed to determine the prevalence of financial toxicity and identify its risk factors in patients with gynecologic cancer treated at a large cancer center using objective data. STUDY DESIGN: Using institutional databases, we identified patients with gynecologic cancer treated from January 2016 to December 2018. Patients with a preinvasive disease were excluded. Financial toxicity was defined according to institutionally derived metrics as the presence of ≥1 of the following: ≥2 bills sent to collections, application or granting of a payment plan, settlement, bankruptcy, financial assistance program enrollment, or a finance-related social work visit. Clinical characteristics were gathered using a 2-year look-back from the time of the first financial toxicity event or a randomly selected treatment date for those not experiencing toxicity. Risk factors were assessed using chi-squared tests. All significant variables on univariate analysis were included in the logistic regression model. RESULTS: Of the 4655 patients included in the analysis, 1155 (25%) experienced financial toxicity. In the univariate analysis, cervical cancer (35%), stage 3 or 4 disease (24% and 30%, respectively), younger age (35% for age <30 years), nonpartnered marital status (31%), Black (45%) or Hispanic (37%) race and ethnicity, self-pay (48%) or commercial insurance (30%), clinical trial participation (31%), more imaging studies (39% for ≥9), ≥1 emergency department visit (36%), longer inpatient stays (36% for ≥20 days), and more outpatient clinician visits (41% for ≥20 visits) were significantly associated with financial toxicity (P<.01). In multivariate analysis, younger age, nonpartnered marital status, Black and Hispanic race and ethnicity, commercial insurance, more imaging studies, and more outpatient physician visits were significantly associated with financial toxicity. CONCLUSION: Financial toxicity is an increasing problem for patients with gynecologic cancer. Our analysis, using objective measures of financial toxicity, has suggested that demographic factors and healthcare utilization metrics may be used to proactively identify at-risk patients for financial toxicity.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Aviki EM, Manning-Geist BL, Sokolowski SS, et al. Risk factors for financial toxicity in patients with gynecologic cancer. Am J Obstet Gynecol. 2021. PMID: 34902319. doi:10.1016/j.ajog.2021.12.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。